|
CDK4/6 Inhibitors Clinical Trials
1 actively recruiting trial
Also known as: Abemaciclib, Palbociclib, Ribociclib
Top Sponsors
- Fundación Santa Fe de Bogota1
Indications
- Triple Negative Breast Neoplasms1
- Breast Neoplasms1
- Hormone Receptor Positive Breast Cancer1
- HER2-positive Breast Cancer1
- Lung Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.